Current Neuro-Oncology
Volume
26 Number 9
15 May 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 9, 15 May
*Hendriksen JD, Locallo A, Maarup S, Debnath O, Ishaque N,
Hasselbach B, Skjøth-Rasmussen J, Yde CW, Poulsen HS,
Lassen U, Weischenfeldt J.
Immunotherapy
drives mesenchymal tumour cell state shift and TME immune response
in glioblastoma patients.
Neuro
Oncol. 2024 May 2:noae085. doi:
10.1093/neuonc/noae085. PMID:
38695342. Observational study˰
ˍ
Kram L, Neu B, Schroeder A, Wiestler B, Meyer B, Krieg SM, Ille
S.
Toward a systematic grading for the
selection of patients to undergo awake surgery: identifying
suitable predictor variables.
Front
Hum Neurosci. 2024 May 2;18:1365215. doi:
10.3389/fnhum.2024.1365215. PMID:
38756845. Observational study. ˍ
Ma J, Cao H, Hou D, Wang W, Liu T.
Investigation
of high-dose radiotherapy's effect on brain structure aggravated
cognitive impairment and deteriorated patient psychological status
in brain tumor treatment.
Sci
Rep. 2024 May 2;14(1):10149. doi:
10.1038/s41598-024-59694-0. PMID:
38698048. Observational study. ˍ
Vizcaino MA, Giannini C, Lalich D, Nael A, Jenkins RB, Tran Q, Orr
BA, Abdullaev Z, Aldape K, Vaubel RA.
Ganglioglioma
with anaplastic/high-grade transformation: Histopathologic,
molecular, and epigenetic characterization of 3 cases.
J
Neuropathol Exp Neurol. 2024 May 2:nlae038. doi:
10.1093/jnen/nlae038. PMID:
38699943.
Case report˰ ˍ
*Babaoglu B, Hanalioglu S, Varan A, Oguz KK, Bilginer B, Dolgun A,
Soylemezoglu F.
Molecular Subgrouping
Based on Immunohistochemistry in Medulloblastoma: a Single-Center
Experience.
Turk
Neurosurg. 2024 May 3. doi:
10.5137/1019-5149.JTN.45863-23.2. PMID:
38874255. Laboratory investigation. ˍ
Li S, Zhao Y, Huang H.
Clinical
characteristics and prognostic factors of adult brainstem gliomas:
A retrospective analysis of histologically-proven 40
cases.
Medicine
(Baltimore). 2024 May 3;103(18):e37910. doi:
10.1097/MD.0000000000037910. PMID:
38701282. Observational study. ˍ
Shin I, Sim Y, Choi SH, Park YW, Lee N, Ahn SS, Chang JH, Kim SH,
Lee SK.
Revisiting prognostic factors
of gliomatosis cerebri in adult-type diffuse gliomas.
J
Neurooncol. 2024 May 3. doi:
10.1007/s11060-024-04656-9. PMID:
38700610. Observational study˰
ˍ
Maier
SH, Schönecker S, Anagnostatou V, Garny S, Nitschmann A,
Fleischmann DF, Büttner M, Kaul D, Imhoff D, Fokas E, Seidel
C, Hau P, Kölbl O, Popp I, Grosu AL, Haussmann J, Budach W,
Celik E, Kahl KH, Hoffmann E, Tabatabai G, Paulsen F, Holzgreve A,
Albert NL, Mansmann U, Corradini S, Belka C, Niyazi M, Bodensohn
R.
Dummy
run for planning of isotoxic dose-escalated radiation therapy for
glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01;
AG-NRO-06).
Clin
Transl Radiat Oncol.
2024 May 4;47:100790. doi:
10.1016/j.ctro.2024.100790. PMID:
38765202. Observational study. ˍ
*Niu Z, Yang Z, Sun S, Zeng Z, Han Q, Wu L, Bai J, Li H, Xia
H.
Clinical analysis of the efficacy of
radiation therapy for primary high-grade gliomas guided by
biological rhythms.
Transl Oncol. 2024 May
4;45:101973. doi: 10.1016/j.tranon.2024.101973. PMID:
38705052. Observational study. ˍ
Strauss I, Gabay S, Roth J.
Laser
interstitial thermal therapy (LITT) for pediatric low-grade
glioma-case presentations and lessons learned.
Childs
Nerv Syst. 2024 May 4. doi:
10.1007/s00381-024-06419-3. PMID:
38703238. Observational study. ˍ
Cossu
G, Vandenbulcke A, Zaccarini S, Gaudet JG, Hottinger AF, Rimorini
N, Potie A, Beaud V, Guerra-Lopez U, Daniel RT, Berna C, Messerer
M.
Hypnosis-Assisted
Awake Craniotomy for Eloquent Brain Tumors: Advantages and
Pitfalls.
Cancers
(Basel).
2024 May 5;16(9):1784. doi:
10.3390/cancers16091784. PMID:
38730736. Observational study. ˍ
Cordier F, Schouten JW, Geurts M, Kros JM, Dubbink HJ, Verlinden
V, Federico A, Kool M, Maas SLN.
Diffuse
infiltrating tumour with the molecular profile of an atypical
teratoid rhabdoid tumour (AT/RT SHH-1B) in an adult
patient.
Neuropathol
Appl Neurobiol. 2024 May 6;50(3):e12983. doi:
10.1111/nan.12983. PMID:
38708554. Case report. ˍ
*Gonzalez-Aponte MF, Damato AR, Simon T, Aripova N, Darby F, Rubin
JB, Herzog ED.
Daily glucocorticoids
promote glioblastoma growth and circadian synchrony to the
host.
bioRxiv
[Preprint]. 2024 May 6:2024.05.03.592418. doi:
10.1101/2024.05.03.592418. PMID:
38766060. Laboratory investigation. ˍ
Ottenhausen M, Renovanz M, Bartz I, Poplawski A, Kalasauskas D,
Krenzlin H, Keric N, Ringel F.
Use of
complementary therapies and supportive measures of patients with
intracranial gliomas-a prospective evaluation in an outpatient
clinic.
J
Neurooncol. 2024 May 6. doi:
10.1007/s11060-024-04696-1. PMID:
38709354. Observational study.
ˍ
*Price M, Neff C, Nagarajan N, Kruchko C, Waite KA, Cioffi G,
Cordeiro BB, Willmarth N, Penas-Prado M, Gilbert MR, Armstrong TS,
Barnholtz-Sloan JS, Ostrom QT.
CBTRUS
Statistical Report: American Brain Tumor Association & NCI
Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and
Other Central Nervous System Tumors Diagnosed in the United States
in 2016-2020.
Neuro
Oncol. 2024 May 6;26(Supplement_3):iii1-iii53. doi:
10.1093/neuonc/noae047. PMID:
38709657. Observational study.
ˍ
Xie MY, Lin ZY, Sun XF, Feng JJ, Mai L, Wu CC, Huang GL, Wang P,
Liu YW, Liu LY, Zeng EY.
Per- and
polyfluoroalkyl substances (PFAS) exposure in plasma and their
blood-brain barrier transmission efficiency-A pilot study.
Environ
Int. 2024 May 6;187:108719. doi:
10.1016/j.envint.2024.108719. PMID:
38718677. Interventional study. ˍ
Anvari K, Seilanian Toussi M, Saghafi M, Javadinia SA, Saghafi H,
Welsh JS.
Extended dosing (12 cycles)
vs conventional dosing (6 cycles) of adjuvant temozolomide in
adults with newly diagnosed high-grade gliomas: a randomized,
single-blind, two-arm, parallel-group controlled trial.
Front
Oncol. 2024 May 7;14:1357789. doi:
10.3389/fonc.2024.1357789. PMID:
38774410. Interventional
study. ˍ
Castelli B, Tellini M, Guidi M, Di Nicola M, Giunti L, Buccoliero
AM, Censullo ML, Iacono A, Desideri I, Genitori L, Sardi I, Fonte
C.
Case report: complete long-lasting
response to multimodal third line treatment with neurosurgical
resection, carmustine wafer implantation and dabrafenib plus
trametinib in a BRAFV600E
mutated high-grade glioma.
Front
Oncol. 2024 May 7;14:1359093. doi:
10.3389/fonc.2024.1359093. PMID:
38774414. Case report. ˍ
Kang KM, Song J, Choi Y, Park C, Park JE, Kim HS, Park SH, Park
CK, Choi SH.
MRI Scoring Systems for
Predicting Isocitrate Dehydrogenase Mutation and Chromosome 1p/19q
Codeletion in Adult-type Diffuse Glioma Lacking Contrast
Enhancement.
Radiology.
2024 May 7;311(2):e233120. doi:
10.1148/radiol.233120. PMID:
38713025. Observational study˰
ˍ
*Castro MP, Quinn J, Wasserman A, Awawda A, Cole ZD, Shapiro MA,
Stuhlmiller TJ, Kesari S.
Proton pump
inhibitors are detrimental to overall survival of patients with
glioblastoma: Results from a nationwide real-world evidence
database.
Neurooncol
Pract. 2024 May 8;11(6):713-722. doi:
10.1093/nop/npae044. PMID:
39554793. Observational study. ˍ
Everson
RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S,
Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy
TF, Liau LM, Prins RM.
TLR
agonists polarize interferon responses in conjunction with
dendritic cell vaccination in malignant glioma: a randomized phase
II Trial.
Nat
Commun.
2024 May 8;15(1):3882. doi:
10.1038/s41467-024-48073-y. PMID:
38719809. Interventional study. ˍ
Nussbaumer
G, Benesch M, Grabovska Y, Mackay A, Castel D, Grill J, Alonso MM,
Antonelli M, Bailey S, Baugh JN, Biassoni V, Blattner Johnson M,
Broniscer A, Carai A, Colafati GS, Colditz N, Corbacioglu S,
Crampsie S, Entz-Werle N, Eyrich M, Friker LL, Frühwald MC,
Garrè ML, Gerber NU, Giangaspero F, Gil-da-Costa MJ, Graf
N, Hargrave D, Hauser P, Herrlinger U, Hoffmann M, Hulleman E,
Izquierdo E, Jacobs S, Karremann M, Kattamis A, Kebudi R, Kortmann
RD, Kwiecien R, Massimino M, Mastronuzzi A, Miele E, Morana G,
Noack CM, Pentikainen V, Perwein T, Pfister SM, Pietsch T, Roka K,
Rossi S, Rutkowski S, Schiavello E, Seidel C, Štěrba
J, Sturm D, Sumerauer D, Tacke A, Temelso S, Valentini C, van
Vuurden D, Varlet P, Veldhuijzen van Zanten SEM, Vinci M, von
Bueren AO, Warmuth-Metz M, Wesseling P, Wiese M, Wolff JEA,
Zamecnik J, Morales La Madrid A, Bison B, Gielen GH, Jones DTW,
Jones C, Kramm CM.
Gliomatosis
cerebri in children: A poor prognostic phenotype of diffuse
gliomas with a distinct molecular profile.
Neuro
Oncol.
2024 May 8:noae080. doi:
10.1093/neuonc/noae080. PMID:
38717379. Observational study. ˍ
Faris
MM, Dhillon HM, Campbell R, Halkett GK, Chan RJ, Haydon HM,
Sansom-Daly UM, Koh ES, Ownsworth T, Nowak AK, Kelly B, Leonard R,
Pike KE, Legge DM, Pinkham MB, Agar MR; BRAINS Program Group; Shaw
J.
Unmet
needs in people with high-grade glioma: Defining criteria for
stepped care intervention.
JNCI
Cancer Spectr.
2024 May 10:pkae034. doi:
10.1093/jncics/pkae034. PMID:
38730547. Observational study. ˍ
Harari CM, Burr AR, Morris BA, Tomé WA, Bayliss A, Bhatia
A, Grogan PT, Robins HI, Howard SP.
Pulsed
reduced-dose rate re-irradiation for patients with recurrent grade
2 gliomas.
Neurooncol
Adv. 2024 May 10;6(1):vdae073. doi:
10.1093/noajnl/vdae073. PMID:
38845694. Observational study. ˍ
*Huang
ZL, Liu ZG, Lin Q, Tao YL, Li X, Baxter P, Su JM, Adesina AM, Man
C, Chintagumpala M, Teo WY, Du YC, Xia YF, Li XN.
Fractionated
radiation therapy alters energy metabolism and induces cellular
quiescence exit in patient-derived orthotopic xenograft models of
high-grade glioma.
Transl
Oncol.
2024 May 10;45:101988. doi:
10.1016/j.tranon.2024.101988. PMID:
38733642. Laboratory investigation. ˍ
Kuang
RZ, Wang J, Wang YC, Tang XP.
Effects
of Apatinib combined with Temozolomide on levels of sPD-1 and
sPD-L1 in patients with drug-resistant recurrent
glioblastoma.
Clinics
(Sao
Paulo). 2024 May 10;79:100376. doi:
10.1016/j.clinsp.2024.100376. PMID:
38733690. Observational study. ˍ
O'Halloran K, Phadnis S, Friedman GK, Metrock K, Davidson TB,
Robison NJ, Tamrazi B, Cotter JA, Dhall G, Margol AS.
Effective
re-induction regimen for children with recurrent medulloblastoma.
Neurooncol
Adv. 2024 May 10;6(1):vdae070. doi:
10.1093/noajnl/vdae070. PMID:
38863988. Observational study. ˍ
Xu
H, Chen X, Sun Y, Hu X, Zhang X, Wang Y, Tang Q, Zhu Q, Song K,
Chen H, Sheng X, Yao Y, Zhuang D, Chen L, Mao Y, Qin
Z.
Comprehensive
molecular characterization of long-term glioblastoma
survivors.
Cancer
Lett.
2024 May 10:216938. doi:
10.1016/j.canlet.2024.216938. PMID:
38734160. Observational study. ˍ
Yu
X, Lai M, Li J, Wang L, Ye K, Zhang D, Hu Q, Li S, Hu X, Wang Q,
Ma M, Xiao Z, Zhou J, Shi C, Luo L, Cai L.
The
relationship between imaging features, therapeutic response, and
overall survival in pediatric diffuse intrinsic pontine
glioma.
Neurosurg
Rev.
2024 May 10;47(1):212. doi:
10.1007/s10143-024-02435-8. PMID:
38727935. Observational study. ˍ
Cerretti G, Padovan M, Guerriero A, Maccari M, Bosio A, Caccese M,
Cella E, Pintacuda G, Librizzi G, Lombardi G.
Prolonged
response to entrectinib in an adult patient with recurrent
glioblastoma harboring a GOPC::ROS1
fusion.
Neurooncol
Adv. 2024 May 11;6(1):vdae077. doi:
10.1093/noajnl/vdae077. PMID:
38845690. Case report. ˍ
*Gonçalves JM, Carvalho B, Tuna R, Polónia P,
Linhares P.
Sequential Evaluation of
Hematology Markers as a Prognostic Factor in Glioblastoma
Patients.
Biomedicines.
2024 May 12;12(5):1067. doi:
10.3390/biomedicines12051067. PMID:
38791033. Observational study. ˍ
Peres N, Lepski GA, Fogolin CS, Evangelista GCM, Flatow EA, de
Oliveira JV, Pinho MP, Bergami-Santos PC, Barbuto JAM.
Profiling
of Tumor-Infiltrating Immune Cells and Their Impact on Survival in
Glioblastoma Patients Undergoing Immunotherapy with Dendritic
Cells.
Int
J Mol Sci. 2024 May 12;25(10):5275. doi:
10.3390/ijms25105275. PMID:
38791312. Observational study. ˍ
da
Silva EB Jr, Vasquez MWM, de Almeida Teixeira BC, Neto MC,
Sprenger F, Filho JLN, Almeida-Lopes L, Ramina R.
Association
of 5-aminolevulinic acid fluorescence guided resection with
photodynamic therapy in recurrent glioblastoma: a matched cohort
study.
Acta
Neurochir (Wien).
2024 May 13;166(1):212. doi:
10.1007/s00701-024-06108-9. PMID:
38739282. Observational study˰ ˍ
Juvekar P, Dorent R, Kögl F, Torio E, Barr C, Rigolo L,
Galvin C, Jowkar N, Kazi A, Haouchine N, Cheema H, Navab N, Pieper
S, Wells WM, Bi WL, Golby A, Frisken S, Kapur T.
ReMIND:
The Brain Resection Multimodal Imaging Database.
Sci
Data. 2024 May 14;11(1):494. doi:
10.1038/s41597-024-03295-z. PMID:
38744868. Observational
study. ˍ
Kumaria
A, Leggate AJ, Dow GR, Ingale HA, Robertson IJA, Byrne PO, Basu S,
Macarthur DC, Smith SJ.
A
common tumour in a rare location: a single centre case series of
cerebellar glioblastoma.
Br
J Neurosurg.
2024 May 14:1-6. doi:
10.1080/02688697.2024.2348598. PMID:
38741545. Case report˰ ˍ
Goulenko V, Madhugiri VS, Bregy A, Recker M, Lipinski L, Fabiano
A, Fenstermaker R, Plunkett R, Abad A, Belal A, Alberico R, Qiu J,
Prasad D.
Histopathological correlation
of brain tumor recurrence vs. radiation effect post-radiosurgery
as detected by MRI contrast clearance analysis: a validation
study.
J
Neurooncol. 2024 May 15. doi:
10.1007/s11060-024-04697-0. PMID:
38748050. Observational
study˰ ˍ
Qu C, Cao Z, Zhou J, He S, Liu F, Liu Z.
Preoperative
walking exercise to improve prognosis in patients with
supratentorial brain tumours after craniotomy: protocol for a
randomised controlled trial.
BMJ
Open. 2024 May 15;14(5):e080787. doi:
10.1136/bmjopen-2023-080787? PMID:
38754891. Interventional study protocol. ˍ
Wawrzuta D, Chojnacka M, Drogosiewicz M, Pędziwiatr K,
Dembowska-Bagińska B.
Reirradiation
for diffuse intrinsic pontine glioma: prognostic radiomic factors
at progression.
Strahlenther
Onkol. 2024 May 15. doi:
10.1007/s00066-024-02241-7. PMID:
38748214. Observational
study. ˍ
***